CorMedix targets $45M-$60M in annual synergies as it expects Heron assets to add $125M-$150M in pro forma 2027 revenue
Open the sourceReported by Seeking Alpha, seekingalpha.com, 12 November 2026
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.